XRCC3 5′-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis

Springer Science and Business Media LLC - 2010
Lixin Qiu1,2, Mao Chen3, Lei Yao4, Ke-Da Yu5,2, Ping Zhan6, Bo Chen7, Haiguang Liu8, Hui Yuan9, Jian Zhang1,2, Kai Xue1,2, Xichun Hu1,2
1Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai, China
2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
3Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, China
4State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China
5Breast Cancer Institute, Department of Breast Surgery, Cancer Hospital, Fudan University, Shanghai, China
6Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, China
7Department of Geriatrics, First Affiliated Hospital, Nanjing Medical University, Nanjing, China
8Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
9Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Anhui, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55:74–108

Lichtenstein P, Holm NV, Verkasalo PK (2000) Environmental and heritable factors in the causation of cancer. N Engl J Med 343:78–85

Brenneman MA, Weiss AE, Nickoloff JA, Chen DJ (2000) XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat Res 459:89–97

Breast Cancer Association Consortium (2006) Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98:1382–1396

Lee SA, Lee KM, Park SK, Choi JY, Kim B, Nam J, Yoo KY, Noh DY, Ahn SH, Kang D (2007) Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case–control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res Treat 103:71–76

Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G (2006) XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 164:297–302

Economopoulos KP, Sergentanis TN (2009) XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0562-3

Han J, Hankinson SE, Ranu H, De Vivo I, Hunter DJ (2004) Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses’ Health Study. Carcinogenesis 25:189–195

Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399–1407

Garcia-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, Chanock S, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N (2006) Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 119:376–388

Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129

Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629–634

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả